Antifungal activity of pomegranate peel extract and isolated compound punicalagin against dermatophytes by Simone R Foss et al.
Foss et al. Annals of Clinical Microbiology and Antimicrobials 2014, 13:32
http://www.ann-clinmicrob.com/content/13/1/32RESEARCH Open AccessAntifungal activity of pomegranate peel extract
and isolated compound punicalagin against
dermatophytes
Simone R Foss1, Celso V Nakamura2, Tania Ueda-Nakamura2, Diógenes AG Cortez3, Eliana H Endo4
and Benedito P Dias Filho2*Abstract
Background: Dermatophyte species infect the epidermis and appendages, often with serious social and
health-economic consequences. The hydroalcoholic extract of pomegranate fruit peel showed activity against the
dermatophyte fungi Trichophyton mentagrophytes, T. rubrum, Microsporum canis and M. gypseum.
Methods: Hydroalcoholic extract was prepared with pomegranate peels. This crude extract was fractionated and
submitted to liquid-liquid partition, resulting in an active fraction which was fractionated in a Sephadex LH-20
column, followed by a Lobar column. The structure of the active compound was established with the use of
spectroscopic methods.
Results: The crude extract of pomegranate fruit peel showed activity against the dermatophytes Trichophyton
mentagrophytes, T. rubrum, Microsporum canis, and M. gypseum, with MICs values of 125 μg/ml and 250 μg/ml,
respectively for each genus. Punicalagin was isolated and identified by spectroscopic analysis. The crude extract and
punicalagin showed activity against the conidial and hyphal stages of the fungi. The cytotoxicity assay showed
selectivity for fungal cells than for mammalian cells.
Conclusions: These results indicated that the crude extract and punicalagin had a greater antifungal activity
against T. rubrum, indicating that the pomegranate is a good target for study to obtain a new antidermatophyte
medicine.Background
Dermatophytes are fungi that use keratin for their nutri-
tion and may cause infections of the nails, skin, and hair,
known as dermatophytosis. These organisms are classified
into three genera: Epidermophyton, Trichophyton, and
Microsporum [1]. Although not life-threatening, superficial
mycoses due to dermatophytes have been among the
most common communicable diseases of humans since
antiquity, and have considerable social and health-
economic implications [2].
Generally, dermatophytes infect the superficial layers of
skin. However, immunocompromised patients, such as
AIDS patients or recipients of kidney transplants, can be
affected by deep injury in the dermal layer, resulting in* Correspondence: bpdfilho@uem.br
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unless otherwise stated.disseminated lesions that may take fatal forms [3-6]. Al-
though many antifungals are available, their side effects
and drug interactions, and the existence of resistant organ-
isms have created a need to find safer and more effective
treatments [7]. Also, dermatophytosis treatments are, in
general, expensive and must be applied over long periods.
Natural products have proven to be an alternative source
of new active molecules. In many countries, mainly in de-
veloping countries, plants have been used as the primary
basic health treatment. The pomegranate Punica grana-
tum is a bush 3 to 5 meters in height, with opposite and
obtuse leaves, flowers with wrinkled white, yellow, or or-
ange petals. The fruit is composed of a yellow to red peel
that covers the seeds, the fleshy arils of which are eaten.
Punica granatum is a plant with worldwide application in
folk medicine. There are references to an antimicrobial
effect of pomegranate products against many pathogenic
bacterial species, including inhibition of formation of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Entamoeba histolytica and Giardia lamblia [12]. Polyphe-
nols extracted from pomegranate fruit rind were active
against phytopathogenic fungi [13]. The extract of P. gran-
atum showed good results as a topical antifungal agent for
the treatment of candidosis associated with denture stoma-
titis [14]. The tannin punicalagin is the major component
of pomegranate fruit peel. This substance was isolated not
only from Punica granatum, but also was described from
Terminallia mollis and Terminallia brachystemma, as hav-
ing antifungal activity against Candida albicans, C. krusei,
and C. parapsilosis [15].
The present study evaluate the antidermatophyte activ-
ity of pomegranate fruit peel extract and investigate its
effect on different fungal development stages, cytotoxicity
and possible mechanisms of action. The active substance
of pomegranate peel was isolated and identified as well.Methods
Plant material and crude extract
Punica granatum fruits were collected in December 2007
in Maringá, Paraná, Brazil. The peel was separated ma-
nually (2183.8 g) and extracted with a 90% (v/v) hydroal-
coholic solution, by maceration at room temperature for
5 days in a dark room. The hydroalcoholic extracts were
filtered, evaporated under vacuum at 40°C, lyophilized,
and kept in a freezer at −10°C. This crude extract was
assayed against four species of dermatophyte fungi and
Gram-positive and Gram-negative bacteria.Isolation of the active substance
First, 200 ml of an aqueous solution of the crude extract
(20 g) was submitted to liquid-liquid partition, and
eluted with ethyl acetate and then with n-butanol; this
procedure was repeatead four times with each solvent,
resulting in three fractions: F1 (water), F2 (ethyl acet-
ate), and F3 (n-butanol). The collected fractions were
evaporated under vacuum and lyophilized in the same
conditions as for the extract. Second, 0.5 g of the frac-
tion with the best activity (F1) was dissolved in water,
filtered through cotton wool and then placed in a
Sephadex LH-20 column. The procedure was performed
twice to maximize the yield. It was monitored by thin-
layer chromatography (TLC), mobile phase n-butanol:
acetic acid: water (40:10:50), and observed as a natural
yellow substance. Finally, after antifungal tests, the ac-
tive subfraction was placed in a Lobar (C-18) column
and eluted with methanol:water (1:1), also monitored by
TLC. The structure of the active compound was estab-
lished with the use of spectroscopic methods (EI-MS,
1H NMR, 13C NMR, H-H COSY, HMBC, HMQC, and
DEPT). The isolated substance was tested against Tri-
chophyton rubrum.Microorganisms and growth conditions
Dermatophyte species used for this investigation were
Microsporum canis ATCC 32903, Microsporum gypseum
ATCC 14683, Trichophyton mentagrophytes ATCC 1481
and Trichophyton rubrum ATCC 28189. Gram-negative
bacteria Pseudomonas aeruginosa ATCC 27853 and Escher-
ichia coli ATCC 25922 and Gram-positive bacteria Bacillus
subtilis ATCC 6623 and Staphylococcus aureus ATCC
25923 were also investigated, because secondary infections
may occur in dermatophytoses.
Microdilution broth assay
Antifungal and antibacterial assays were performed by
microdilution method in sterile flat-bottom microplates
according to CLSI [16,17]. Each well contained appropriate
test samples, culture medium, and approximately 105 cells
for bacteria, and 104 spores in a total volume of 100 μl. The
plates were incubated at 37°C and 24 h for bacteria and
28°C during 72 h for dermatophytes. The MIC (Minimal
Inhibitory Concentration) was defined as the lowest con-
centration of a compound at which the microorganism
tested did not demonstrate visible growth. To determine
the minimal fungicidal effect, 10 μl of suspension from the
MIC was spotted in Sabouraud agar and incubated for 24
to 72 h at 28°C. The minimum fungicidal concentration
(MFC) was defined as the lowest concentration that
yielded negative subcultures or only one colony.
Conidial germination inhibition assay
Different concentrations of test samples in 90 μl were pre-
pared in 96-well flat-bottom micro-culture plates by the
double dilution method. The wells were prepared in dupli-
cate for each concentration. An inoculum of 10 μl of spore
suspension containing 2000–3000 spores was added to
each well. Plates were incubated at 28°C for 24 h and then
examined for spore germination under an inverted micro-
scope. For analysis, spores were considered germinated if
they had a germ tube at least twice the length of the spore.
Disc diffusion method
Disc diffusion method and fluorescence microscopy were
used to evaluate the hyphal growth inhibition. Plates with
Sabouraud Dextrose Agar were centrally inoculated with
T. rubrum and incubated at 28°C for 3–5 days. Test discs
were made with the extract, punicalagin, and Nystatin,
with concentrations close to the MIC. These discs and
one control disc (with 10 μl of sterile water) were arranged
around the colony on the plate, at a distance of 0.5 cm,
and incubated at 28°C for 72 h. The hyphal growth inhib-
ition was evaluated visually and photographed [18].
Fluorescence microscopy
Sub-inhibitory concentrations of the crude extract in 500 μl
of culture medium were prepared by the double-dilution
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which round cover slips were placed. The wells were
prepared in duplicate for each concentration. The wells
were inoculated with 50 μl of spore suspension, contain-
ing 10,000–15,000 spores. The plates were incubated at
28°C for 24 h. Then, the cover slips carefully removed
were and washed in PBS, pH 7.2, with light manual
shaking. Next, the medium was carefully removed and
cover slips with adhered cells were stained with Calcofluor
White M2R (Sigma, St. Louis, MO, USA) and mounted
on a slide with synthetic resin (Araldite 502™). Slides were
viewed by means of a Zeiss fluorescent microscope [19].Cytotoxicity assay
Confluent Vero cell monolayers grown in 96-well cell-
culture plates were incubated with a tenfold serial dilution
of punicalagin, starting with a concentration of 1000 μg/
ml - for 48 h at 37°C and 5% CO2. At that time, cultures
fixed with 10% trichloroacetic acid for 1 h at 4°C were
stained for 30 min with 0.4% sulforhodamine B (SRB) in
1% acetic acid and subsequently washed with distilled
water. Bound SRB was solubilized with 150 ml 10 mM
Tris-base solution. Absorbance was read in an ELISA plate
reader at 530 nm. The cytotoxicity was expressed as a per-












Minimal inhibitory concentration (MIC) of crude extract of Punica granatum
against bacteria and dermatophytes species.Results and discussion
Isolation of active substance
From 2183.8 g of pomegranate fruit peel, 220.6 g of crude
extract was obtained, a yield of 10.1%. Pomegranate fruit
peel is rich in tannins, high-molecular-weight plant poly-
phenols, which can be classified into two chemically and
biologically distinct groups: condensed tannin and hy-
drolyzable tannin, the latter composed of phenolic acids
and glycosyl esters. Hydrolyzable tannins are separated
into ellagitannins (containing ellagic acid) and gallotannins
(containing gallic acid) [20]. The structure of active com-
pound, punicalagin, obtained by successive bioactive-
guided steps, was established by spectroscopic methods
(EI-MS, 1H NMR, 13C NMR, H-H COSY, HMBC,
HMQC, and DEPT). Punicalagin has been isolated from
plants [21] by different methods. However, some of the
isolation techniques, such as high-speed countercurrent
chromatography, require expensive apparatus [22]. The
present method is a less expensive alternative to obtain
punicalagin with excellent results, and resembles a purifi-
cation procedure reported [23]. The spectral analysis was
compared with that reported by Doig et al. [24], which
confirmed the isolated substance as punicalagin. The mass
spectrum (EI-MS) of the punicalagin isolated confirmed to
that reported by Seeram et al. [23]. Punicalagin anomers
can be observed in the mass spectrum, which show double
chemical shifts at the same carbon or hydrogen.Punicalagin FAB-MS at m/z 1083.4 found C48H28O30.
The 13C NMR results: δ 88.78 (C-1), 69.73 (C-2), 75.33
(C-3), 73.13 (C-4), 65.38 (C-5), 63.23 (C-6), 168.26 (C-7),
124.59 (C-8), 105.61/108.71 (C-9), 144.72 (C-10), 135.67
(C-11), 144.72 (C-12), 114.42 (C-13), 113.87 (C-14), 144.62
(C-15), 135.5 (C-16), 144.4 (C-17), 105.02/108.71 (C-18),
124.24 (C-19),168.45/148.57 (C-20), 167.6 (C-21), 123.57
(C-22), 109.51 (C-23), 144.39 (C-24), 137.76 (C-25), 144.39
(C-26), 117.7 (C-27), 109.51 (C-28), 147.35 (C-29), 136.86
(C-30), 135.5 (C-31),112/113.37 (C-32), 121.75/121.87
(C-33), 157.81 (C-34), 112.56/113.37 (C-35), 135.18
(C-36),136.86/139.2 (C-37), 147.35 (C-38), 109.51 (C-39),
121.75/121.87 (C-40), 157.3 (C-41),113.87 (C-42), 144.36
(C-43), 134.88 (C-44), 144.11 (C-45), 105.02/108.71 (C-
46), 124.59 (C-47), 168.20 (C-48). HMBC1H-13C and 1H
results: 5.06/5.13 (H-C1, m), 4.65/4.71 (H-C2, m),5.06/
5.13 (H-C3, m), 4.65/4.71 (H-C4, m), 3.09/3.17 (H-C5, m),
4.03 (Hα-C6, m), 1.83 (Hβ-C6,d), 6.39/6.41 (H-C9, s),
6.28/6.41 (H-C18, s), 6.7 (H-C23, s), 6.28/6.41 (H-C46, s).Antifungal effect
Crude extract from pomegranate showed a considerable
inhibitory effect against both genera Trichophyton and
Microsporum (Table 1) with MIC of 125 and 250 μg/ml,
respectively. Results of specific tests against T. rubrum are
presented in Table 2. The isolated compound punicalagin
showed about the same MIC value as the crude extract,
probably because punicalagin is the majority substance.
Nystatin showed MIC of 0.39 μg/ml for all dermatophytes
tested. The minimal fungicidal concentration of the crude
extract against T. rubrum was within two-twofold dilution
of the MIC for this organism. Plant products tested for
use against dermatophytes have shown activity against
T. rubrum [19,25,26]. Although the mechanisms of action
were not elucidated, we eliminated the possibility of com-
plexation with the membrane ergosterol (data not shown)
Table 2 Antifungal activity (μg/ml) against Trichophyton
rubrum
Antifungal activity (μg/ml) against Trichophyton
rubrum
MIC MFC CGI
Crude extract 125 250 62.5
Fractions
P1 125 125 62.5
P2 250 250 -
P3 125 125 -
Punicalagin 62.5 125 62.5
Nystatin 0,78 - 0,39
Minimal inhibitory concentration (MIC), minimal fungicidal concentration
(MFC) and conidal germination inhibition (CGI) of pomegranate fruit peel
extract, fractions and the isolated substance punicalagin.
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structures.
Under certain conditions, dermatophytosis can be com-
plicated by secondary bacterial infections. Therefore, we
investigated whether the hydroalcoholic extract exerts, in
addition to its antifungal effects, a significant antibacterial
activity against Gram-negative and Gram-positive bacteria.
The crude extract from pomegranate showed good activity
on S. aureus, B. subtilis and P. aeruginosa with MICs of
62.5, 62.5 and 250 μg/ml. E. coli MIC >1000 μg/ml were
considered resistant (Table 1).
Conidial germination
There are two phases of fungal growth, conidial germin-
ation and hyphal growth, in which drug action can occur.
Conidial germination inhibition occurred at concentration
of 62.5 μg/ml for both crude extract and punicalagin. Ny-
statin was able to inhibit conidial germination at 0.39 μg/
ml. This is particularly noteworthy because the MICs






Figure 1 Disc diffusion method. Antifungal activity in solid medium agai
(B) Nystatin – 6.25, 3.15, 1.56, 0.78, 0.39 μg/ml. Water was used as control (125 μg/ml. This similar effect of the extract and isolated
substance is due to the fact that punicalagin is the majority
substance in the pomegranate fruit peel [22].
Disc diffusion
Disc diffusion is simple and inexpensive agar-based
method which enables the determination of activity of dif-
ferent substances against microrganisms. Here, the hyphal
growth inhibition is shown with disc diffusion of crude
extract and Nystatin in agar. In Figure 1, discs containing
at least 250 μg/ml of crude extract inhibited hyphal
growth of T. rubrum.
Fluorescence microscopy
Calcofluor White stain was used to show possible fungal
cell wall alterations. Figure 2 shows strong inhibition of
hyphal growth on T. rubrum treated with crude extract
at 125 μg/ml (Figure 2B) and inhibition of conidial
germination by punicalagin at 62.5 μg/ml (Figure 2C).
Although no morphological alterations were detected,
this procedure was important to understand and confirm
the inhibition of the hyphal growth and conidial germin-
ation, using the same incubation conditions. This may
be explained by the nature of the principal substance,
punicalagin, which is a tannin. The tannins could act on
the microorganism cell membrane, switching its me-
tabolism; complexing with metallic ions needed for the
microorganism’s metabolism; and inhibiting fungal and
bacterial enzymes by complexation with substrates [21].
Cytotoxicity assay
Cytotoxicity was monitored using SRB assays. Cell viability
after exposure to 100 μg/ml of crude extract, fraction P1,
and punicalagin was 83%, 99%, and 90%, respectively (data
not shown). The concentration of punicalagin with 50%
cytotoxicity (CC50 value) on Vero cell was 400 μg/ml,







nst T. rubrum. (A) Crude extract – 1000, 500, 250, 125, 62.5 μg/ml.
C-). Data correspond to one representative experiment out of three.
AB D
C
Figure 2 Fluorescence microscopy by Calcofluor White Stain. Spore germination inhibition of T. rubrum on cover slips. (A) Control cells;
(B) Treated with 125 μg/ml crude extract; (C) Treated with 62.5 μg/ml punicalagin; (D) Treated with 0.78 μg/ml Nystatin. Data correspond to one
representative experiment out of three.
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crude extract may be ideal for use in topical form. The
values of CC50 of punicalagin are similar to those that have
been reported, with CC50 as 460 μg/ml [21]. The acute
toxicity evaluated, in vivo, using Wistar rats with intrana-
sal administration, and detected that the LD50 (the dose
that can kill 50% of the assayed animals) was 731 mg/ml
[27]. Pomegranate juice may contain 2 g/L of punicalagin.
Sprague–Dawley rats fed a diet containing 6% punicalagin,
for 37 days, showed no toxicity [28]. These data support
the initial idea of a treatment with crude extract of pom-
egranate fruit peel in the topical form.Conclusions
Pomegranate extract inhibited the growth of T. rubrum,T.
mentagrophytes, M. canis and M. gypseum. Spectroscopic
analyses revealed punicalagin as the active substance. The
antidermatophyte assay, using Trichophyton rubrum as a
model, showed that the crude extract acts on conidial and
hyphal structures. Also, cytotoxicity assay showed that
punicalagin was more selective for fungal than mammal
cells, indicating its probable best use in clinical applica-
tions. These results indicated that the crude extract and
punicalagin had a greater antifungal activity against T.
rubrum, indicating that pomegranate is a good target for
study due to its potential future use as a new therapeutic
alternative against dermatophytosis.Competing interests
The authors declared that they have no competing interests.Authors’ contributions
SRF carried out the phytochemical and microbiological studies and drafted
the manuscript. CVN and TUN participated in microscopy and cytotoxicity
assays. DAGC participated in spectroscopic assays. EHE participated with
microbiological assays and draft the manuscript. BPDF conceived of the
study, and participated in its design and coordination and helped to draft
the manuscript. All authors read and approved the final manuscript.
Acknowledgements
This study was supported by Conselho Nacional de Desenvolvimento
Científico e Tecnológico (CNPq), Capacitação e Aperfeiçoamento de
Pessoal de Nível Superior, (Capes), Fundação Araucária, and Programa de
Pós-graduação em Ciências Farmacêuticas da Universidade Estadual de
Maringá. Part of the experiments were carried out at the Complexo de
Central de Apoio a Pesquisa (COMCAP) MCT/FINEP/UEM.
Author details
1Post graduation in Microbiology, Universidade Estadual de Londrina,
Londrina, PR, Brazil. 2Department of Health Sciences, Universidade Estadual
de Maringá, Maringá, PR, Brazil. 3Departament of Pharmacy, Universidade
Estadual de Maringá, Maringá, PR, Brazil. 4Post graduation in Pharmaceutical
Sciences, Universidade Estadual de Maringá, Maringá, PR, Brazil.
Received: 13 December 2013 Accepted: 13 July 2014
Published: 11 March 2015
References
1. Rinaldi MG: Dermatophytosis: Epidemiological and microbiological
update. J Am Acad Dermatol 2000, 43:120–124.
2. Johnson L: Dermatophytes- the skin eaters. Mycologist 2003, 17:147–149.
3. Tsang P, Jimenez-Lucho V: Deep dermatophytosis caused by Trichophyton
rubrum in a patient with AIDS. J Am Acad Dermatol 1996, 34:1090–1091.
4. Seçkin D, Haberal M: Deep dermatophytosis caused by Trichophyton
rubrum with concomitant disseminated nocardiosis in a renal transplant
recipient. J Am Acad Dermatol 2004, 51:173–176.
5. Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E: Infections
due to emerging and uncommon medically important fungal
pathogens. Clin Microbiol Infect 2004, 10:48–66.
6. Pelegrini A, Takahashi JP, Pereira CQM, Pessoni RB, Souza MC: Incidence of
dermatophytosis in a public hospital of São Bernardo do Campo, São
Paulo State, Brazil. Ver Iberoam Micol 2009, 26:118–120.
Foss et al. Annals of Clinical Microbiology and Antimicrobials 2014, 13:32 Page 6 of 6
http://www.ann-clinmicrob.com/content/13/1/327. Straten MRV, Hossain MA, Ghannoum MA: Cutaneous infections
Dermatophytosis, onychomycosis and Tinea versicolor. Infect Dis Clin
North Am 2003, 17:87–112.
8. Meléndrez PA, Capriles VA: Antibacterial properties of tropical plants from
Puerto Rico. Phytomedicine 2006, 13:272–276.
9. Al-Zoreky NS: Antimicrobial activity of pomegranate (Punica granatum L.)
fruit. Int J Food Microbiol 2009, 134:244–248.
10. Dell’Agli M, Galli GV, Corbett Y, Taramelli D, Lucantoni L, Habluetzel A, Maschi O,
Caruso D, Giavarini F, Romeo S, Bhattacharia D, Bosisio E: Antiplasmodial activity
of Punica granatum L. fruit rind. J Ethnopharmacol 2009, 125:279–285.
11. Bakkiyaraj D, Nandhini JR, Malathy B, Pandian SK: The antibiofilm potential
of pomegranate (Punica granatum L.) extract against human bacterial
and fungal pathogens. Biofouling 2013, 29:929–937.
12. Calzada F, Yépez-Mulia L, Aguilar A: In vitro susceptibility of Entamoeba histolytica
and Giardia lamblia to plants used in Mexican tradicional medicine for the
treatment of gastrointestinal disorders. J Ethnopharmacol 2006, 108:367–370.
13. Osorio E, Flores M, Hernández D, Ventura J, Rodríguez R, Aguilar CN:
Biological Efficiency of polyphenolic extracts from pecan nuts Shell
(Carya illionensis), pomegranate husk (Punica granatum) and creosote
bush leaves (Iarrea tridentate Cov.) against plant pathogenic fungi.
Ind Crops Prod 2010, 31:153–157.
14. Vasconcelos LCS, Sampaio MCC, Sampaio FC, Higino JS: Use of Punica
granatum as an antifungal agent against candidosis associated with
denture stomatitis. Mycoses 2003, 46:192–196.
15. Liu M, Katerere DR, Gray AI, Seidel V: Phytochemical and antifungal studies on
Terminalia mollis and Terminalia brachystemma. Fitoterapia 2009, 80:369–373.
16. Clinical and Laboratory Standards Institute: Reference Method for Broth
Dilution Antifungals Susceptibility Testing of Conidium-Forming Filamentous
Fungi: Approved Standard, M38-A2. 2nd edition. Wayne: CLSI; 2008.
17. Clinical and Laboratory Standards Institute: Methods for Dilution
Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically. Approved
Standard, M07-A9. 9th edition. Wayne: CLSI; 2012.
18. Prasad NR, Anandi C, Balasubramanian S, Pegalendi KV: Antidermatophyte
activity of extracts from Psoralea coryfolia (Fabaceae) correlated with the
presence of a flavonoid compound. J Ethnopharmacol 2001, 91:21–24.
19. Koroishi AM, Foss SR, Cortez DAG, Ueda-Nakamura T, Nakamura CV, Dias
Filho BP: In vitro antifungal activity of extracts and neolignans from Piper
regnelli against dermatophytes. J Ethnopharmacol 2008, 117:270–277.
20. Cunha AP, Silva AP, Roque OR, Cunha E: Plantas e produtos vegetais em cosmética
e dermatologia. Lisboa: Editora Fundação Caloustre Gulbenkian; 2004:310.
21. Kulkarni AP, Mahal HS, Kapoor S, Aradhya SM: In vitro studies on the
binding, antioxidant, and cytotoxic actions of Punicalagin. J Agric Food
Chem 2007, 55:1491–1500.
22. Lu J, Wei Y, Yuan Q: Preparative separation of punicalagin from
pomegranate husk by high-speed countercurrent chromatography.
J Chromatogr B 2007, 857:175–179.
23. Seeram N, Lee R, Hardy M, Heber D: Rapid large scale purification of
ellagitannins from pomegranate husk, a by-product of the commercial
juice industry. Sep Purif Technol 2005, 41:49–55.
24. Doig AJ, Williams DH, Oelrichs PB, Baczynsky JL: Isolation and structure
elucidation of punicalagin, a toxic hydrolysable tannin, from Terminalia
oblonga. J Chem Soc Perkin Trans 1990, 673:2317–2321.
25. Aljabre SHM, Randhawa MA, Akhtar N, Alakloby OM, Algurashi AM, Aldossary A:
Antidermatophyte activity of ether extract of Nigella sativa and its active
principle, thymoquinone. J Ethnopharmacol 2005, 101:116–119.
26. Svetaz L, Zuljan F, Derita M: Value of the ethnomedical information for
the discovery of plants with antifungal properties. A survey among
seven Latin American countries. J Ethnopharmacol 2010, 127:137–158.
27. Vidal A, Fallarero A, Peña BR, Medina ME, Gra B, Rivera F, Gutierrez Y, Vuorela
PM: Studies on t toxicity of Punica granatum L. (punicaceae) whole fruit
extracts. J Ethnopharmacol 2003, 89:295–300.
28. Cerda B, Cerón JJ, Tomás-Barberá T, Espín JC: Repeated oral administration
of high doses of the pomegranate ellagitannin punicalagin to rats for
37 days is not toxic. J Agric Food Chem 2003, 51:3493–3501.
doi:10.1186/s12941-014-0032-6
Cite this article as: Foss et al.: Antifungal activity of pomegranate peel
extract and isolated compound punicalagin against dermatophytes.
Annals of Clinical Microbiology and Antimicrobials 2014 13:32.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
